Pulmonary Hypertension: Clinical Updates (CURE) Archived

 
 100% of survey complete.
We are pleased that you participated in one of our SOWEGA-AHEC educational programs. Please take the time to fill out this evaluation survey, so that we can improve future programs.

For continuing education certificate, completion and submission of evaluation (including 75% score or better on post-test) are required. Continuing education certificates will be mailed to the participants.

Question Title

* 1. Please provide your name and email address so that we may identify registrants that complete the evaluation survey for continuing education certificates. We will send reminder emails to those that do not complete the evaluation survey.

Question Title

* 2. Please indicate your professional degree.

Question Title

* 3. Did you participate in the SOWEGA-AHEC CURE activity from your organization's facilities?

Question Title

* 4. If yes, were there other individuals who viewed the presentation with you?

Question Title

* 5. If yes, please provide their names and email addresses, so we may have a complete record of participants and be able to forward evaluation link to them.

Question Title

* 6. At the end of this presentation, the participant should be able to:

  Strongly Agree Agree Somewhat Agree (Neutral) Disagree Strongly Disagree
Increased or refreshed his/her knowledge as a result of the activity.
Describe the pathophysiology of pulmonary hypertension and its adverse impact on the heart.
Recognize the disease and order appropriate testing for patients.
Discuss the various diagnostic invasive and noninvasive tests which aid in diagnostic and therapeutic decisions.
Determine best course of treatment for pulmonary hypertension.

Question Title

* 7. Please rate the following aspects of the program content:

  Excellent Good Fair Poor
Overall Content
Clinical Applications & Objectives Achieved
Presentation Style & Visual Aids

Question Title

* 8. How would you rate the quality of instruction?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Instructional materials were well organized.
Instructional methods illustrated the concepts well.
If slides were presented,they will be useful reference.
References and resources provided will assist me.

Question Title

* 9. How would you rate the quality of the presentation?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Presenter was clear and to the point.
Presenter demonstrated mastery of the topic.
Methods used to present the materials held my attentions.
Presenter was responsive to questions.

Question Title

* 10. Do you intend to implement or advocate for at least one service/practice improvement as a result of what you learned in this educational activity?

Question Title

* 11. Compared to other online activities that you have participated in over the past year, I would rate this program as on a scale from 5 (Great Program) to 1(Needs Improvement):

Question Title

* 12. Where did you hear about this specific activity? (Multiple responses allowed.)

Question Title

* 13. Please rate the following aspects of the distance-based network.

  Very satisfied Satisfied Neutral Dissatisfied Very Dissatisfied
Ease of access to program.
Quality of the video/slides.
Quality of the audio.
Degree of interactivity.

Question Title

* 14. Please describe difficulties if any that you encountered in participating in the activity from your location.

Question Title

* 15. What one suggestion if any would you recommend to the distance based aspect of the activity?

Question Title

* 16. Practice-based learning & improvement CME Needs: Do you have a question in your practice that needs to be answered?

Question Title

* 17. Comments:

Question Title

* 18. Post Test Question #1

39-year-old woman with progressive WHO class II dyspnea and lower extremity edema presents to your office for further evaluation. Her echocardiogram reveals moderate right ventricular dysfunction in the setting of an estimated right ventricular systolic pressure of 86 mmHG. She then has right heart catheterization with pulmonary vasodilator testing using nitric oxide. Measurements are below (abbreviations include right atria (RA), mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and pulmonary vascular resistance (PVR).

Baseline/ Nitric Oxide (80 ppm)
RA (mmHg): 10/ 8
mPAP (mmHg): 58/ 32
PCWP (mmHg): 6/ 7
CO (L/min): 4.6/ 4.8
PVR (Wood units): 11.3/ 5.2



What is the best management option for the patient?

Question Title

* 19. Post Test Question #2

64-year-old man with scleroderma and severe pulmonary arterial hypertension, on intravenous Epoprostenol, Ambrisentan, and Tadalafil, presents with worsening dyspenea (WHO IV), angina and syncope. A repeat echocardiogram was compared to one performed six months prior. The right ventricle reveals severely reduced systolic function with severe tricuspid regurgitation. The right ventricular systolic pressure was 64 mmHg. Previously the right ventricular function was moderately reduced and the right ventricular systolic pressure was 98 mmHg. What is the most likely explanation for the drop in estimated pulmonary pressures on the most recent echocardiogram?

Question Title

* 20. Post Test Question #3

Which one of the following represents the best predictor for poor outcome in patients with pulmonary arterial hypertension?

Question Title

* 21. Post Test Question #4

40-year-old woman presents with dyspnea and lower extremity edema. On exam, there is jugular venous distention, loud P2, and 3/6 harsh systolic murmur in the left lower sternal border. Doppler echocardiography demonstrates mild right ventricular dysfunction, right ventricular hypertrophy, and a right ventricular systolic pressure of 72 mmHg. Based on evidence-based guidelines, which one of the following additional tests in not recommended?

Question Title

* 22. If you are a student viewing the activity as part of your academic pursuit within a specific course, the following additional responses are required.

( Privacy & Cookie Notice

T